Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals.

Jog NR, Young KA, Munroe ME, Harmon MT, Guthridge JM, Kelly JA, Kamen DL, Gilkeson GS, Weisman MH, Karp DR, Gaffney PM, Harley JB, Wallace DJ, Norris JM, James JA.

Ann Rheum Dis. 2019 Sep;78(9):1235-1241. doi: 10.1136/annrheumdis-2019-215361. Epub 2019 Jun 19.

2.

Screening characteristics for enrichment of individuals at higher risk for transitioning to classified SLE.

Young KA, Munroe ME, Guthridge JM, Kamen DL, Gilkensen GS, Harley JB, Weisman MH, Karp DR, Wallace DJ, James JA, Norris JM.

Lupus. 2019 Apr;28(5):597-606. doi: 10.1177/0961203319834675. Epub 2019 Mar 7.

PMID:
30845880
3.

Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial.

Olsen NJ, James JA, Arriens C, Ishimori ML, Wallace DJ, Kamen DL, Chong BF, Liao D, Chinchilli VM, Karp DR.

Trials. 2018 Dec 20;19(1):694. doi: 10.1186/s13063-018-3076-7.

4.

We All Agree: Nobody Likes Maintenance of Certification.

Karp DR.

Arthritis Care Res (Hoboken). 2019 Mar;71(3):331-333. doi: 10.1002/acr.23822. Epub 2019 Feb 6. No abstract available.

PMID:
30570830
5.

Mock Recruitment for the Study of Antimalarials in an Incomplete Lupus Erythematosus Trial.

Karp DR, Chong BF, James JA, Arriens C, Ishimori M, Wallace DJ, Liao D, Olsen NJ.

Arthritis Care Res (Hoboken). 2019 Nov;71(11):1425-1429. doi: 10.1002/acr.23802.

PMID:
30369087
6.

Antinuclear antibodies in the general population: positive association with inflammatory and vascular biomarkers but not traditional cardiovascular risk factors.

Solow EB, Vongpatanasin W, Skaug B, Karp DR, Ayers C, de Lemos JA.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1031-1037. Epub 2018 Sep 17.

7.

The role of cardiovascular disease risk assessed by ASCVD score in primary thrombosis prophylaxis strategy among antiphospholipid antibody carriers.

Zuo Y, Udupa A, Fan J, Makris UE, Karp DR, Shen YM.

Lupus. 2018 Nov;27(13):2177-2178. doi: 10.1177/0961203318796289. Epub 2018 Aug 31. No abstract available.

8.

Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosus.

Young KA, Munroe ME, Harley JB, Guthridge JM, Kamen DL, Gilkensen GS, Weisman MH, Karp DR, Wallace DJ, James JA, Norris JM.

Lupus. 2018 Aug;27(9):1524-1531. doi: 10.1177/0961203318778368. Epub 2018 May 28.

9.

Health Care-Seeking Characteristics of Women With Pelvic Floor Disorders After Obstetric Anal Sphincter Injury.

Pennycuff JF, Karp DR, Shinnick J, Hudson CO, Northington GM.

Female Pelvic Med Reconstr Surg. 2019 Sep/Oct;25(5):383-387. doi: 10.1097/SPV.0000000000000583.

PMID:
29629963
10.

Identifying Additional Risk Factors for Thrombosis and Pregnancy Morbidities Among Antiphospholipid Antibodies Carriers.

Zuo Y, Fan J, Sarode R, Zhang S, Makris UE, Karp DR, Shen YM.

Clin Appl Thromb Hemost. 2018 Sep;24(6):980-985. doi: 10.1177/1076029618755946. Epub 2018 Feb 22.

11.

Restorative Justice as the Rx for Mistreatment in Academic Medicine: Applications to Consider for Learners, Faculty, and Staff.

Acosta D, Karp DR.

Acad Med. 2018 Mar;93(3):354-356. doi: 10.1097/ACM.0000000000002037.

PMID:
29087964
12.

Transancestral mapping and genetic load in systemic lupus erythematosus.

Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA, Bijl M, Brown EE, Brunner HI, Cardiel MH, Catoggio L, Cervera R, Cucho-Venegas JM, Dahlqvist SR, D'Alfonso S, Da Silva BM, de la Rúa Figueroa I, Doria A, Edberg JC, Endreffy E, Esquivel-Valerio JA, Fortin PR, Freedman BI, Frostegård J, García MA, de la Torre IG, Gilkeson GS, Gladman DD, Gunnarsson I, Guthridge JM, Huggins JL, James JA, Kallenberg CGM, Kamen DL, Karp DR, Kaufman KM, Kottyan LC, Kovács L, Laustrup H, Lauwerys BR, Li QZ, Maradiaga-Ceceña MA, Martín J, McCune JM, McWilliams DR, Merrill JT, Miranda P, Moctezuma JF, Nath SK, Niewold TB, Orozco L, Ortego-Centeno N, Petri M, Pineau CA, Pons-Estel BA, Pope J, Raj P, Ramsey-Goldman R, Reveille JD, Russell LP, Sabio JM, Aguilar-Salinas CA, Scherbarth HR, Scorza R, Seldin MF, Sjöwall C, Svenungsson E, Thompson SD, Toloza SMA, Truedsson L, Tusié-Luna T, Vasconcelos C, Vilá LM, Wallace DJ, Weisman MH, Wither JE, Bhangale T, Oksenberg JR, Rioux JD, Gregersen PK, Syvänen AC, Rönnblom L, Criswell LA, Jacob CO, Sivils KL, Tsao BP, Schanberg LE, Behrens TW, Silverman ED, Alarcón-Riquelme ME, Kimberly RP, Harley JB, Wakeland EK, Graham RR, Gaffney PM, Vyse TJ.

Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021.

13.

Use of SLICC criteria in a large, diverse lupus registry enables SLE classification of a subset of ACR-designated subjects with incomplete lupus.

Aberle T, Bourn RL, Chen H, Roberts VC, Guthridge JM, Bean K, Robertson JM, Sivils KL, Rasmussen A, Liles M, Merrill JT, Harley JB, Olsen NJ, Karp DR, James JA.

Lupus Sci Med. 2017 Mar 17;4(1):e000176. doi: 10.1136/lupus-2016-000176. eCollection 2017.

14.

Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls.

Aberle T, Bourn RL, Munroe ME, Chen H, Roberts VC, Guthridge JM, Bean K, Robertson JM, Sivils KL, Rasmussen A, Liles M, Merrill JT, Harley JB, Olsen NJ, Karp DR, James JA.

Arthritis Care Res (Hoboken). 2017 Dec;69(12):1780-1788. doi: 10.1002/acr.23201. Epub 2017 Nov 14.

15.

Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death.

Arriens C, Chen S, Karp DR, Saxena R, Sambandam K, Chakravarty E, James JA, Merrill JT.

Clin Immunol. 2017 Dec;185:3-9. doi: 10.1016/j.clim.2016.11.019. Epub 2016 Dec 3.

16.

Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features.

Munroe ME, Young KA, Kamen DL, Guthridge JM, Niewold TB, Costenbader KH, Weisman MH, Ishimori ML, Wallace DJ, Gilkeson GS, Karp DR, Harley JB, Norris JM, James JA.

Arthritis Rheumatol. 2017 Mar;69(3):630-642. doi: 10.1002/art.40004.

17.

Indications and Complications Associated with the Removal of 506 Pieces of Vaginal Mesh Used in Pelvic Floor Reconstruction: A Multicenter Study.

Miklos JR, Chinthakanan O, Moore RD, Karp DR, Nogueiras GM, Davila GW.

Surg Technol Int. 2016 Oct 26;29:185-189.

PMID:
27780347
18.

The Indication and Surgical Treatment of 286 Midurethral Synthetic Sling Complications: A Multicenter Study.

Chinthakanan O, Miklos JR, Moore RD, Karp DR, Nogueiras GM, Davila GW.

Surg Technol Int. 2016 Oct 26;29:167-171.

PMID:
27780346
19.

Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus.

Young KA, Munroe ME, Guthridge JM, Kamen DL, Niewold TB, Gilkeson GS, Weisman MH, Ishimori ML, Kelly J, Gaffney PM, Sivils KH, Lu R, Wallace DJ, Karp DR, Harley JB, James JA, Norris JM.

Ann Rheum Dis. 2017 Jan;76(1):153-158. doi: 10.1136/annrheumdis-2016-209157. Epub 2016 Jun 9.

20.

Cross-sectional imaging of adult crystal and inflammatory arthropathies.

Soldatos T, Pezeshk P, Ezzati F, Karp DR, Taurog JD, Chhabra A.

Skeletal Radiol. 2016 Sep;45(9):1173-91. doi: 10.1007/s00256-016-2402-y. Epub 2016 May 21. Review.

PMID:
27209200
21.

Urinary neurotrophic peptides in postmenopausal women with and without overactive bladder.

Pennycuff JF, Schutte SC, Hudson CO, Karp DR, Malykhina AP, Northington GM.

Neurourol Urodyn. 2017 Mar;36(3):740-744. doi: 10.1002/nau.23011. Epub 2016 Apr 6.

PMID:
27062604
22.

Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity.

Raj P, Rai E, Song R, Khan S, Wakeland BE, Viswanathan K, Arana C, Liang C, Zhang B, Dozmorov I, Carr-Johnson F, Mitrovic M, Wiley GB, Kelly JA, Lauwerys BR, Olsen NJ, Cotsapas C, Garcia CK, Wise CA, Harley JB, Nath SK, James JA, Jacob CO, Tsao BP, Pasare C, Karp DR, Li QZ, Gaffney PM, Wakeland EK.

Elife. 2016 Feb 15;5. pii: e12089. doi: 10.7554/eLife.12089.

23.

Obstetric Anal Sphincter Injury as a Quality Metric: 16-Year Experience at a Single Institution.

Pennycuff JF, Northington GM, Loucks T, Suciu G, Karp DR.

Obstet Gynecol. 2016 Mar;127(3):496-500. doi: 10.1097/AOG.0000000000001199.

PMID:
26855095
24.

The IUGA/ICS classification of synthetic mesh complications in female pelvic floor reconstructive surgery: a multicenter study.

Miklos JR, Chinthakanan O, Moore RD, Mitchell GK, Favors S, Karp DR, Northington GM, Nogueiras GM, Davila GW.

Int Urogynecol J. 2016 Jun;27(6):933-8. doi: 10.1007/s00192-015-2913-4. Epub 2015 Dec 21.

PMID:
26690360
25.

Concomitant apical suspensory procedures in women with anterior vaginal wall prolapse in the United States in 2011.

Northington GM, Hudson CO, Karp DR, Huber SA.

Int Urogynecol J. 2016 Apr;27(4):613-9. doi: 10.1007/s00192-015-2894-3. Epub 2015 Dec 2.

PMID:
26630948
26.

A subset of CD163+ macrophages displays mixed polarizations in discoid lupus skin.

Chong BF, Tseng LC, Hosler GA, Teske NM, Zhang S, Karp DR, Olsen NJ, Mohan C.

Arthritis Res Ther. 2015 Nov 13;17:324. doi: 10.1186/s13075-015-0839-3.

27.

Apical Suspension at the Time of Hysterectomy for Uterovaginal Prolapse: A Comparative Analysis of 2001 and 2011.

Hudson CO, Karp DR, Loucks TL, Northington GM.

Female Pelvic Med Reconstr Surg. 2015 Nov-Dec;21(6):343-7. doi: 10.1097/SPV.0000000000000199.

PMID:
26506163
28.

Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus.

Arriens C, Hynan LS, Lerman RH, Karp DR, Mohan C.

Nutr J. 2015 Aug 18;14:82. doi: 10.1186/s12937-015-0068-2.

29.

Antinuclear Antibodies Are Associated With All-Cause Mortality and Cardiovascular Outcomes in the General Population.

Solow EB, Vongpatanasin W, Skaug B, Karp DR, Ayers C, de Lemos JA.

J Am Coll Cardiol. 2015 Jun 23;65(24):2669-2670. doi: 10.1016/j.jacc.2015.03.578. No abstract available.

30.

Bowel and bladder dysfunction following surgery within the presacral space: an overview of neuroanatomy, function, and dysfunction.

Huber SA, Northington GM, Karp DR.

Int Urogynecol J. 2015 Jul;26(7):941-6. doi: 10.1007/s00192-014-2572-x. Epub 2014 Nov 20. Review.

PMID:
25410373
31.

Outcomes of robotic sacrocolpopexy: a systematic review and meta-analysis.

Hudson CO, Northington GM, Lyles RH, Karp DR.

Female Pelvic Med Reconstr Surg. 2014 Sep-Oct;20(5):252-60. doi: 10.1097/SPV.0000000000000070. Review.

32.

Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls.

Young KA, Terrell DR, Guthridge JM, Kamen DL, Gilkeson GS, Karp DR, Ishimori ML, Weisman MH, Holers VM, Harley JB, Norris JM, James JA.

Lupus. 2014 Apr;23(4):360-9. doi: 10.1177/0961203314520838. Epub 2014 Jan 21.

33.

Complete transvaginal surgical management of multiple bladder calculi and obstructed uterine procidentia.

Hudson CO, Sinno AK, Northington GM, Galloway NT, Karp DR.

Female Pelvic Med Reconstr Surg. 2014 Jan-Feb;20(1):59-61. doi: 10.1097/SPV.0b013e318288ad82. Review.

PMID:
24368492
34.

Autoantibodies and SLE: the threshold for disease.

Olsen NJ, Karp DR.

Nat Rev Rheumatol. 2014 Mar;10(3):181-6. doi: 10.1038/nrrheum.2013.184. Epub 2013 Dec 3. Review.

PMID:
24296678
35.

Discovery of biomarkers for systemic lupus erythematosus using a library of synthetic autoantigen surrogates.

Quan J, Lakhanpal A, Reddy MM, Zaman S, Li QZ, German DC, Olsen NJ, Kodadek T, Karp DR.

J Immunol Methods. 2014 Jan 15;402(1-2):23-34. doi: 10.1016/j.jim.2013.11.004. Epub 2013 Nov 20.

36.

Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations.

Kim-Howard X, Sun C, Molineros JE, Maiti AK, Chandru H, Adler A, Wiley GB, Kaufman KM, Kottyan L, Guthridge JM, Rasmussen A, Kelly J, Sánchez E, Raj P, Li QZ, Bang SY, Lee HS, Kim TH, Kang YM, Suh CH, Chung WT, Park YB, Choe JY, Shim SC, Lee SS, Han BG, Olsen NJ, Karp DR, Moser K, Pons-Estel BA, Wakeland EK, James JA, Harley JB, Bae SC, Gaffney PM, Alarcón-Riquelme M; GENLES, Looger LL, Nath SK.

Hum Mol Genet. 2014 Mar 15;23(6):1656-68. doi: 10.1093/hmg/ddt532. Epub 2013 Oct 26.

37.

Vulvar mass in a patient with type 1 neurofibromatosis.

Schirmer DA, Mittal P, Karp DR.

J Minim Invasive Gynecol. 2014 Mar-Apr;21(2):179-80. doi: 10.1016/j.jmig.2013.08.708. Epub 2013 Sep 4. No abstract available.

PMID:
24012924
38.

SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature.

Becker AM, Dao KH, Han BK, Kornu R, Lakhanpal S, Mobley AB, Li QZ, Lian Y, Wu T, Reimold AM, Olsen NJ, Karp DR, Chowdhury FZ, Farrar JD, Satterthwaite AB, Mohan C, Lipsky PE, Wakeland EK, Davis LS.

PLoS One. 2013 Jun 24;8(6):e67003. doi: 10.1371/journal.pone.0067003. Print 2013.

39.

Organ damage in high-risk patients with systemic and incomplete lupus syndromes.

Olsen NJ, Yousif M, Mutwally A, Cory M, Elmagboul N, Karp DR.

Rheumatol Int. 2013 Oct;33(10):2585-90. doi: 10.1007/s00296-013-2783-3. Epub 2013 May 30.

40.

Multifaceted effects of hydroxychloroquine in human disease.

Olsen NJ, Schleich MA, Karp DR.

Semin Arthritis Rheum. 2013 Oct;43(2):264-72. doi: 10.1016/j.semarthrit.2013.01.001. Epub 2013 Mar 5. Review.

PMID:
23481418
41.

Repeat versus primary slings in patients with intrinsic sphincter deficiency.

Smith AL, Karp DR, Aguilar VC, Davila GW.

Int Urogynecol J. 2013 Jun;24(6):963-8. doi: 10.1007/s00192-012-1953-2. Epub 2012 Oct 25.

PMID:
23096532
42.

Autoantibody profiling to follow evolution of lupus syndromes.

Olsen NJ, Li QZ, Quan J, Wang L, Mutwally A, Karp DR.

Arthritis Res Ther. 2012 Jul 27;14(4):R174. doi: 10.1186/ar3927.

43.

A randomized clinical trial of the impact of local estrogen on postoperative tissue quality after vaginal reconstructive surgery.

Karp DR, Jean-Michel M, Johnston Y, Suciu G, Aguilar VC, Davila GW.

Female Pelvic Med Reconstr Surg. 2012 Jul-Aug;18(4):211-5. doi: 10.1097/SPV.0b013e31825e6401.

PMID:
22777369
44.

IgG and IgM autoantibody differences in discoid and systemic lupus patients.

Chong BF, Tseng LC, Lee T, Vasquez R, Li QZ, Zhang S, Karp DR, Olsen NJ, Mohan C.

J Invest Dermatol. 2012 Dec;132(12):2770-9. doi: 10.1038/jid.2012.207. Epub 2012 Jul 5.

45.

Did drug therapy contribute?: severe pelvic organ prolapse followed initiation of high-dose glucocorticoid treatment.

Zoulek ES, Karp DR, Davila GW.

Am J Obstet Gynecol. 2012 Mar;206(3):265.e1-2. doi: 10.1016/j.ajog.2011.12.034. Epub 2012 Jan 4. No abstract available.

PMID:
22381607
46.

Predictors of successful salpingo-oophorectomy at the time of vaginal hysterectomy.

Karp DR, Mukati M, Smith AL, Suciu G, Aguilar VC, Davila GW.

J Minim Invasive Gynecol. 2012 Jan-Feb;19(1):58-62. doi: 10.1016/j.jmig.2011.09.008. Epub 2011 Nov 4.

PMID:
22055729
47.

Rectovaginal fistula as a complication to a Bartholin gland excision.

Zoulek E, Karp DR, Davila GW.

Obstet Gynecol. 2011 Aug;118(2 Pt 2):489-91. doi: 10.1097/AOG.0b013e3182235548.

PMID:
21768863
48.

LeFort colpocleisis and stress incontinence: weighing the risk of voiding dysfunction with sling placement.

Smith AL, Karp DR, Lefevre R, Aguilar VC, Davila GW.

Int Urogynecol J. 2011 Nov;22(11):1357-62. doi: 10.1007/s00192-011-1441-0. Epub 2011 May 13.

PMID:
21567261
49.

Symptomatic vaginal enterocele associated with malfunctioning ventriculoperitoneal shunt and cerebrospinal ascites.

Karp DR, Rizvi TZ, Davila GW.

Int Urogynecol J. 2011 Sep;22(9):1189-91. doi: 10.1007/s00192-011-1420-5. Epub 2011 Apr 13.

PMID:
21487828
50.

Biologic grafts for cystocele repair: does concomitant midline fascial plication improve surgical outcomes?

Karp DR, Peterson TV, Mahdy A, Ghoniem G, Aguilar VC, Davila GW.

Int Urogynecol J. 2011 Aug;22(8):985-90. doi: 10.1007/s00192-011-1408-1. Epub 2011 Apr 12.

PMID:
21484371

Supplemental Content

Support Center